Analysis across major SGC subtypes—including salivary duct, adenoid cystic, and mucoepidermoid carcinomas—reveals that CD47 expression is prominent not only on malignant cells but also on tumor-infiltrating immune cells (TIICs) (116). This evidence concerns the gene CD47 and neoplasm.